Adherence to biologic DMARD therapies in rheumatoid arthritis

Author： Koncz Tamas   Pentek Marta   Brodszky Valentin   Ersek Katalin   Orlewska Ewa   Gulacsi Laszlo  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.9, 2010-09, pp. : 1367-1378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel biologic therapies for psoriasis

By Barry Jane   Kirby Brian  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 6, 2004-06 ,pp. : 975-987

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for rheumatoid arthritis

By Ghivizzani Steven C   Gouze Elvire   Gouze Jean-Noel   Palmer Glyn D   Evans Christopher H   Robbins Paul D  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 971-978

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in the treatment of rheumatoid arthritis

By Voulgari Paraskevi V   Kaltsonoudis Evripidis   Papagoras Charalampos   Drosos Alexandros A  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1679-1686

Informa Healthcare

Access to resources Recommend Favorite

Etanercept in the treatment of rheumatoid arthritis

By Hunt Laura   Emery Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1441-1450

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibody treatments for rheumatoid arthritis

By Bossaller Lukas  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1257-1272

Informa Healthcare

Access to resources Recommend Favorite